Advertisement

Lower quality of life, lower limb pain with neuropathic characteristics, female sex, and ineffective metabolic control are predictors of depressive symptoms in patients with type 2 diabetes mellitus treated in primary care

  • Luciano Ramos de Lima
  • Marina Morato Stival
  • Silvana Schwerz Funghetto
  • Cris Renata Grou Volpe
  • Tania Cristina Morais Santa Barbara Rehem
  • Walterlânia Silva Santos
  • Mani Indiana Funez
Original Article
  • 14 Downloads

Abstract

The primary objective of this study was to identify if lower limb pain with neuropathic characteristics is predictive of depressive symptoms in patients with type 2 diabetes mellitus (T2DM) treated in primary care in Brazil. It was investigated if diabetic and non-diabetic related variables could influence depressive symptoms. A quantitative and cross-sectional study was carried out in two Basic Health Units with users of the Brazilian Public Healthcare System, who were evaluated for depressive symptoms (BDI), quality of life (QoL, SF6D), pain intensity, neuropathy (loss of plantar sensitivity—LOPPS), body composition (DEXA), biochemical tests, sociodemographic variables, and comorbidities. The patients were stratified into four groups: N+P+, N+P, NP+, and NP (N = neuropathy and P = pain). One hundred twenty-one diabetics were selected by random sampling between August 2016 and June 2017. Neuropathy affected 53.8% of these individuals, and 59.5% reported intense pain. Overall depressive symptoms scores showed a positive correlation with pain intensity and a negative correlation with QoL. Depressive symptoms were reported by 66.9% of the sample, mostly female, with better levels of cholesterol, HDL and LDL; comorbidities; worse QoL; greater intensity of pain; impaired sleep; and painful neuropathy (N+P+). The predictive factors for depressive symptoms were lower QoL, pain with neuropathic characteristics, female sex, obesity, and ineffective glycemic control. These data may contribute to the understanding of the complexity of patients with T2DM who are treated in primary care and to public policies planning of care directed at the needs of this population.

Keywords

Depression Diabetes mellitus Type 2 Pain Diabetic neuropathies Diabetes complications 

Notes

Acknowledgments

We would like to offer thanks to all patients who accepted to participate in this study. We also thank the director and the team of the Health Units of Ceilândia; the Foundation of Support to Research of the Federal District (FAP-DF) for financing this research; the Department of Health (SES-DF) for authorizing the development of this research; and the members of the Health Care and Aging Research Group-GEPSEN/UnB, professors, and students (PhD, master’s degree, scientific initiation, and volunteers) for the help in the development of this work.

Author contribution

LRL, MIF, and MMS worked on study design, data collection and analysis, interpretation, drafting, and editing of the manuscript. CRGV, TCMSBR, WSS, and SSF collaborated on interpretation, data analysis, editing, and review of the manuscript data. All authors read and approved the final manuscript.

Compliance with ethical standards

After the draw, the patient was invited to participate in the study. The data collection occurred in the Basic Health Units, after the approval of the ethics committee and signature of the participant in the free and informed consent term. Participants received a description of the study and were informed about the purpose, risks, and benefits. This research was approved by the Ethics Committee of the Health Department of the Federal District (SES/DF) number 1355211/2015 and CAAE (50367215.5.0000.5553).

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Semenkovich K, Brown M, Svrakic D, Lustman P. Depression in type 2 diabetes mellitus: prevalence, impact and treatment. Drugs. 2015;75(6):77–587.  https://doi.org/10.1007/s40265-015-0347-4.CrossRefGoogle Scholar
  2. 2.
    Siddiqui S. Depression in type 2 diabetes mellitus—a brief review. Diabetes Metab Syndr Clin Res Rev. 2014;8(1):62–5.  https://doi.org/10.1016/j.dsx.2013.06.010.CrossRefGoogle Scholar
  3. 3.
    Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37(3):278–316. https://www.ncbi.nlm.nih.gov/pubmed/27159875.  https://doi.org/10.1210/er.2015-1137.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Bruce D, Davis W, Hunter M, Peters K, Davis T, Starkstein S. Lifetime depression history and depression risk in type 2 diabetes: a case-control study. J Diabetes Complicat. 2015;30(1):38–42.  https://doi.org/10.1016/j.jdiacomp.2015.10.010.CrossRefPubMedGoogle Scholar
  5. 5.
    Tapash RE, Lloyd C. Epidemiology of depression and diabetes: a systematic review. J Affect Disord. 2012;142(Sup):S8–S21.  https://doi.org/10.1016/S0165-0327(12)70004-6.Google Scholar
  6. 6.
    Palizgir M, Bakhtiari M, Esteghamati A. Association of depression and anxiety with diabetes mellitus type 2 concerning some sociological factors. Iran Red Crescent Med J. 2013;15(8):644–8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918186/pdf/ircmj-15-644.pdf.  https://doi.org/10.5812/ircmj.12107.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T. How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia. 2006;49(3):469–77. https://link.springer.com/article/10.1007%2Fs00125-005-0094-2.  https://doi.org/10.1007/s00125-005-0094-2.CrossRefPubMedGoogle Scholar
  8. 8.
    Dias LS, Nienov OH, Goelzer Neto CF, Schmid H. Unsteady walking as a symptom in type 2 diabetes mellitus: independent association with depression and sedentary lifestyle and no association with diabetic neuropathy. Braz J Med Biol Res. 2018;51(5):1–7.  https://doi.org/10.1590/1414-431x20186605.CrossRefGoogle Scholar
  9. 9.
    Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord. 2012;31(142):8–21.  https://doi.org/10.1016/S0165-0327(12)70004-6.CrossRefGoogle Scholar
  10. 10.
    World Health Organization. Depression - a global public health concern. WHO Department of Mental Health and Substance Abuse [Internet]; 2012. http://www.who.int/mental_health/management/depression/who_paper_depression_wfmh_2012.pdf. Accessed 10 Jan 2018.
  11. 11.
    D’Amato C, Morganti R, Greco C, Gennaro FD, Cacciotti L, Longo S, et al. Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities. Diab Vasc Dis Res. 2016;13(6):418–28. http://journals.sagepub.com/doi/pdf/10.1177/1479164116653240 CrossRefPubMedGoogle Scholar
  12. 12.
    Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional de Saúde. Percepção do estado de saúde, estilos de vida e doenças crônicas [Internet]. Rio de Janeiro: Instituto Brasileiro de Geografia e Estatística; 2013. p. 2014. ftp://ftp.ibge.gov.br/PNS/2013/pns2013.pdf Google Scholar
  13. 13.
    Ramos LBS, Santana CN, Araújo LLC, Jesus GP, Gois CFL, Santos FLSG, et al. Qualidade de Vida, Depressão e Adesão ao Tratamento de Pessoas com Diabetes Mellitus Tipo 2. R Bras ci Saúde. 2017;21(3):261–8. http://periodicos.ufpb.br/ojs2/index.php/rbcs/article/view/29085.  https://doi.org/10.4034/RBCS.2017.21.03.10.CrossRefGoogle Scholar
  14. 14.
    Malik RA, Aldinc E, Chan SP, Deerochanawong C, Hwu CM, Rosales RL, et al. Perceptions of painful diabetic peripheral neuropathy in South-East Asia: results from patient and physician surveys. Adv Ther. 2017;34(6):1426–37. https://link.springer.com/content/pdf/10.1007%2Fs12325-017-0536-5.pdf.  https://doi.org/10.1007/s12325-017-0536-5.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Mirghani HO, Elbadawi AS. Depression, anxiety and daytime sleepiness among type 2 diabetic patients and their correlation with the diabetes control: a case-control study. J Taibah Univ Med Sc. 2016;11(4):374–79. https://www.sciencedirect.com/science/article/pii/S1658361216300427.Google Scholar
  16. 16.
    Mishra SR, Sharma A, Bhandari PM, Bhochhibhoya S, Thapa K. Depression and Health-related quality of life among patients with type 2 diabetes mellitus: a cross-sectional study in Nepal. PLoS One. 2015;10(11):1–13. https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26599008/ CrossRefGoogle Scholar
  17. 17.
    Ishizawa K, Babazono T, Horiba Y, Nakajima J, Takasaki K, Miura L, et al. The relationship between depressive symptoms and diabetic complications in elderly patients with diabetes: analysis using the Diabetes Study from the Center of Tokyo Women’s Medical University (DIACET). J Diabetes Complicat. 2016;30(4):597–602. https://www.ncbi.nlm.nih.gov/pubmed/26987919.  https://doi.org/10.1016/j.jdiacomp.2016.02.004.CrossRefPubMedGoogle Scholar
  18. 18.
    Atif M, Saleem Q, Scahill S. Depression and mild cognitive impairment (MCI) among elderly patients with type 2 diabetes mellitus in Pakistan: possible determinants. Int J Diabetes Dev Ctries 2017;28.  https://doi.org/10.1007/s13410-017-0600-3
  19. 19.
    Andreoulakis E, Hyphantis T, Kandylis D, Iacovides A. Depression in diabetes mellitus: a comprehensive review. Hippokratia. 2012;16(3):205–14. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738724/pdf/hippokratia-16-205.pdf PubMedPubMedCentralGoogle Scholar
  20. 20.
    Xiaoyun K, Hailong Z, Qingzhi W. Effect of community management of diabetes mellitus on patients with type 2 diabetes mellitus concomitant with depression. Int J Diabetes Dev Ctries. 2017;37(4):478–82.  https://doi.org/10.1007/s13410-016-0525-2.CrossRefGoogle Scholar
  21. 21.
    Bouhassira D, Letanoux M, Hartemann A. Chronic pain with neuropathic characteristics in diabetic patients: a French cross-sectional study. PLoS One. 2013;8(9):1–9. http://www.ncbi.nlm.nih.gov/pubmed/24058527 CrossRefGoogle Scholar
  22. 22.
    Doğan R, Arslantas D, Ünsal A. Assessment of depression and death anxiety level in diabetic patients in Eskisehir, Turkey. Int J Diabetes Dev Ctries. 2015;35(3):242–9.  https://doi.org/10.1007/s13410-014-0254-3.CrossRefGoogle Scholar
  23. 23.
    Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Champaign: HumanKinetics Books; 1988.  https://doi.org/10.1007/BF01941027.Google Scholar
  24. 24.
    Faludi AA, Izar MCO, Saraiva JFK, Chacra APM, Bianco HT, Afiune Neto A, et al. Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose—2017. Arq Bras Cardiol. 2017;109(Suppl1):1–76.  https://doi.org/10.5935/abc.20170121.Google Scholar
  25. 25.
    Diretrizes Da Sociedade Brasileira De Diabetes (2015–2016) organização José Egidio Paulo de Oliveira, Sérgio Vencio - São Paulo: A.C. Farmacêutica, 2016. http://www.diabetes.org.br/profissionais/images/docs/DIRETRIZES-SBD-2015-2016.pdf Accessed 20 Jan 2018.
  26. 26.
    Pedrosa HP. Polineuropatia Diabética: novas estratégias para diagnóstico e intervenção terapêutica precoces—Diretrizes NeurALAD. In: The Latin America Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) March 11–14, 2010. Buenos Aires, Argentina. p.2–8. http://www.anad.org.br/profissionais/images/Highlight_CODHy_Buenos_Aires_Dra_Herme linda_Pedrosa_7505.pdf,  https://doi.org/10.4240/wjgs.v2.i10.324.
  27. 27.
    American Diabetes Association (ADA) Diabetes Guidelines 2016 [Internet] Summary Recommendations from NDEI. Disponível em: http://www.ndei.org/ADA-diabetes-management-guidelines-diagnosis-A1C-testing.aspx Accessed 20 Jan 2018.
  28. 28.
    Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Manual do pé diabético : estratégias para o cuidado da pessoa com doença crônica / Ministério da Saúde, Secretaria de Atenção à Saúde, Departamento de Atenção Básica. – Brasília : Ministério da Saúde, 2016. http://189.28.128.100/dab/docs/portaldab/publicacoes/manual_do_pe_diabetico.pdf Accessed 20 Jan 2018.
  29. 29.
    Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4(6):561–71. https://jamanetwork.com/journals/jamapsychiatry/article-abstract/487993?redirect=true.  https://doi.org/10.1001/archpsyc.1961.01710120031004.CrossRefPubMedGoogle Scholar
  30. 30.
  31. 31.
    Lustman PJ, Clouse RE, Griffith LS, Carney RM, Freedland KE. Screening for depression in diabetes using the Beck Depression Inventory. Psychosom Med. 1997;59(1):24–31.  https://doi.org/10.1097/00006842-199701000-00004.CrossRefPubMedGoogle Scholar
  32. 32.
    Moreira RO, Amâncio APRL, Brum HR, Vasconcelos DL, Nascimento GF. Depressive symptoms and quality of life in type 2 diabetic patients with diabetic distal polyneuropathy. Arq Bras Endocrinol Metabol. 2009;53(9):1103–11.  https://doi.org/10.1590/S0004-27302009000900007.CrossRefPubMedGoogle Scholar
  33. 33.
    Papelbaum M, Moreira R, Coutinho W, Kupfer R, Zagury L, Freitas S, et al. Depression, glycemic control and type 2 diabetes. Diabetol Metab Syndr. 2011;3(1):26. https://www.ncbi.nlm.nih.gov/pubmed/21978660.  https://doi.org/10.1186/1758-5996-3-26.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Papelbaum M, Appolinário JC, Moreira RO, Ellinger VCM, Kupfer R, Coutinhol WF. Prevalence of eating disorders and psychiatric comorbidity in a clinical sample of type 2 diabetes mellitus patients. Rev Bras Psiquiatr. 2005;27(2):135–8. https://www.ncbi.nlm.nih.gov/pubmed/15962139.  https://doi.org/10.1590/S1516-44462005000200012.CrossRefPubMedGoogle Scholar
  35. 35.
    Campolina AG, Bortoluzzo AB, Ferraz MB, Ciconelli RM. Validação da versão brasileira do questionário genérico de qualidade de vida short-form 6 dimensions (SF-6D Brasil). Ciênc Saúde Coletiva. 2011;16(7):3103–10.  https://doi.org/10.1590/S1413-81232011000800010.CrossRefGoogle Scholar
  36. 36.
    Akena D, Kadama P, Ashaba S, Akello C, Kwesiga B, Rejani L, et al. The association between depression, quality of life, and the health care expenditure of patients with diabetes mellitus in Uganda. J Affect Disord. 2015;174:7–12. www.ncbi.nlm.nih.gov/pubmed/25479048.  https://doi.org/10.1016/j.jad.2014.11.019.CrossRefPubMedGoogle Scholar
  37. 37.
    Blay S, Fillenbaum G, Marinho V, Andreoli S, Gastal F. Increased health burden associated with comorbid depression in older Brazilians with diabetes. J Affect Disord. 2011;134(1–3):77–84. https://www.ncbi.nlm.nih.gov/pubmed/10333904 CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Moreira RO, Papelbaum M, Appolinario JC, Matos MA, Coutinho WF, Meirelles RMR, et al. Diabetes mellitus e depressão: uma revisão sistemáticaDiabetes mellitus and depression: a systematic review. Arq Bras Endocrinol Metab. 2003;47(1):19–29.  https://doi.org/10.1590/S0004-27302003000100005.CrossRefGoogle Scholar
  39. 39.
    Derakhshanpour F, Vakili MA, Farsinia M, Mirkarimi K. Depression and quality of life in patients with type 2 diabetes. Iran Red Crescent Med J. 2015;17(5):1–6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464375/ CrossRefGoogle Scholar
  40. 40.
    Papanas N, Vinik AI, Ziegler D. Neuropathy in prediabetes: does the clock start ticking early? Nat Rev Endocrinol. 2011;7(11):682–90.  https://doi.org/10.1038/nrendo.2011.113.CrossRefPubMedGoogle Scholar
  41. 41.
    Tesfaye S. Recent advances in the management of diabetic distal symmetrical polyneuropathy. J Diabetes Investig. 2011;2(1):33–42. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008012.  https://doi.org/10.1111/j.2040-1124.2010.00083.x.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Torrance N, Ferguson JA, Afolabi E, Bennett MI, Serpell MG, Dunn KM, et al. Neuropathic pain in the community: more under-treated than refractory. Pain. 2013;154(5):690–9 Available from: http://www.ncbi.nlm.nih.gov/pubmed/23485369.  https://doi.org/10.1016/j.pain.2012.12.022.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Geelen CC, Smeets RJEM, Schmitz S, Van Den Bergh JP, Goossens MEJB, Verbunt JA. Anxiety affects disability and quality of life in patients with painful diabetic neuropathy. Eur J Pain. 2017;21(10):1632–41. https://www.ncbi.nlm.nih.gov/pubmed/28656745.  https://doi.org/10.1002/ejp.1067.CrossRefPubMedGoogle Scholar
  44. 44.
    Hecke OV, Austin SK, Khan RA, Smith BH, Torrance N. Neuropathic pain in the general population: a systematic review of epidemiological studies. PAIN. 2014;155:654–62. https://www.ncbi.nlm.nih.gov/pubmed/24291734.  https://doi.org/10.1016/j.pain.2013.11.013.CrossRefPubMedGoogle Scholar
  45. 45.
    Hébert HL, Veluchamy A, Torrance N, Smith BH. Risk factors for neuropathic pain in diabetes mellitus. Pain. 2017;158(4):560–8.  https://doi.org/10.1097/j.pain.0000000000000785.CrossRefPubMedGoogle Scholar
  46. 46.
    International Association for the Study of Pain. Mecanismos da Dor Neuropática. [Internet] 2015. http://www.sbed.org.br/sites/arquivos/downloads/o_que_e_dor_neuropatica.pdf Accessed 20 Jan 2018.
  47. 47.
    Emre N, Topal K, Edirne T, Gereklioglu Ç. Factors affecting risk of anxiety and depression among diabetic and hypertensive patients who refer to family health centers. Int J Diabetes Dev Ctries. 2017;  https://doi.org/10.1007/s13410-017-0592-z.
  48. 48.
    Singh H, Raju MS, Dubey V, Kurrey R, Bansal S, Malik M. A study of sociodemographic clinical and glycemic control factors associated with co-morbid depression in type 2 diabetes mellitus. Ind Psychiatry J. 2014;23(2):134–42. https://www.ncbi.nlm.nih.gov/pubmed/25788803.  https://doi.org/10.4103/0972-6748.151687.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Mut-Vitcu G, Timar B, Timar R, Oancea C, Citu IC. Depression influences the quality of diabetes-related self-management activities in elderly patients with type 2 diabetes: a cross-sectional study. Clin Interv Aging. 2016;11:471–9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853012/.  https://doi.org/10.2147/CIA.S104083.PubMedPubMedCentralGoogle Scholar
  50. 50.
    Sweileh WM, Abu-Hadeeb HM, Al-Jabi SW, Zyoud SH. Prevalence of depression among people with type 2 diabetes mellitus: a cross sectional study in Palestine. BMC Public Health. 2014;14(163):1–11.  https://doi.org/10.1186/1471-2458-14-163.Google Scholar

Copyright information

© Research Society for Study of Diabetes in India 2018

Authors and Affiliations

  • Luciano Ramos de Lima
    • 1
  • Marina Morato Stival
    • 1
  • Silvana Schwerz Funghetto
    • 1
  • Cris Renata Grou Volpe
    • 1
  • Tania Cristina Morais Santa Barbara Rehem
    • 1
  • Walterlânia Silva Santos
    • 1
  • Mani Indiana Funez
    • 1
  1. 1.Nursing Course University of Brasília (UnB), School of Ceilândia (FCE)BrasíliaBrazil

Personalised recommendations